Compare Aurora Cannabis Inc (ACB) vs Live Nation Entertainment, Inc. (LYV) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Live Nation (LYV) trades at $183.92, down 1.43% with a bullish technical signal despite recent earnings misses. The stock shows strong analyst support with 88.6% buy ratings and a $194 consensus target. Revenue growth remains solid at $25.2B for 2025, though profitability metrics are weak with a 0.33% net margin and negative ROE. Recent news highlights strong concert demand and strategic initiatives.

Outlook remains positive driven by live event recovery and ticketing dominance, but elevated valuation ratios and profitability challenges present risks. The stock faces headwinds from legal expenses and consumer spending pressures, requiring careful monitoring of execution against growth expectations.